Psoriasis is a chronic inflammatory skin disease affecting 2–3% of the global population.
Traditional systemic treatments, such as methotrexate, cyclosporine, acitretin and fumaric …

Psoriasis is a highly prevalent dermatological disease associated with an increased
systemic inflammatory response. In addition, joint involvement is also present in around 20 …

Psoriasis is a complex and chronic inflammatory disease. Current drugs help control the
symptoms of psoriasis but make no cure, urging discovery of novel drugs. We report in this …

Cannabidiol (CBD), a non-psychoactive compound from Cannabis sativa, has shown
efficacy in treating psoriasis, a chronic inflammatory skin disease affecting 1–3% of the …

Psoriasis is a chronic inflammatory skin disease characterized by the excessive proliferation
of keratinocytes and heightened immune activation. Targeting pathogenic genes through …

Introduction The use of the current available therapies for psoriasis management may
sometimes be limited by reduced patients' compliance, safety issues for patients' …

Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms,
including inverse, erythrodermic, pustular, guttate, plaque types. While current therapies …

Psoriasis is an immune-mediated skin condition. There are many therapeutic options for its
treatment; however, none of them is completely effective. Tapinarof is a promising new …

In recent years, there have been significant breakthroughs in the identification of
immunological components of skin diseases and in the development of immunomodulatory …

Aim: Meta-analysis study to investigate the physical activity in psoriasis patients. Methods:
We designed this study according to the Systematic Reviews and Meta-Analyses (PRISMA) …